Abstract:ABSTRACT Bacteria exposed to bactericidal treatment, such as antibiotics or bacteriophages (phages), often develop resistance. While phage therapy is proposed as a solution to the antibiotic resistance crisis, the bacterial resistance emerging during phage therapy remains poorly characterized. In this study, we examined a large population of phage-resistant extra-intestinal pathogenic Escherichia coli 536 clones that emerged from both in vitro (non-limited liquid medium) and in vivo (murine pneumonia) conditions. Genome sequencing uncovered a convergent mutational pattern in phage resistance mechanisms under both conditions, particularly targeting two cell-wall components, the K15 capsule and the lipopolysaccharide (LPS). This suggests that their identification in vivo could be predicted from in vitro assays. Phage-resistant clones exhibited a wide range of fitness according to in vitro tests, growth rate, and resistance to amoeba grazing, which could not distinguish between the K15 capsule and LPS mutants. In contrast, K15 capsule mutants retained virulence comparable to the wild-type strain, whereas LPS mutants showed significant attenuation in the murine pneumonia model. Additionally, we observed that resistance to the therapeutic phage through a nonspecific mechanism, such as capsule overproduction, did not systematically lead to co-resistance to other phages that were initially capable or incapable of infecting the wild-type strain. Our findings highlight the importance of incorporating a diverse range of phages in the design of therapeutic cocktails to target potential future phage-resistant clones effectively. IMPORTANCE This study isolated more than 50 phage-resistant mutants from both in vitro and in vivo conditions, exposing an extra-intestinal pathogenic Escherichia coli strain to a single virulent phage. The characterization of these clones revealed several key findings: (1) mutations occurring during phage treatment affect the same pathways as those identified in vitro ; (2) the resistance mechanisms are associated with the modification of two cell-wall components, with one involving receptor deletion (phage-specific mechanism) and the other, less frequent, involving receptor masking (phage-nonspecific mechanism); (3) an in vivo virulence assay demonstrated that the absence of the receptor abolishes virulence while masking the receptor preserves it; and (4) clones with a resistance mechanism nonspecific to a particular phage can remain susceptible to other phages. This supports the idea of incorporating diverse phages into therapeutic cocktails designed to collectively target both wild-type and phage-resistant strains, including those with resistance mechanisms nonspecific to a phage.

Temporal shifts in antibiotic resistance elements govern phage-pathogen conflicts

Temporal Shifts in Antibiotic Resistance Elements Govern Virus-Pathogen Conflicts

Phage‐resistant mutations impact bacteria susceptibility to future phage infections and antibiotic response

Phage predation, disease severity, and pathogen genetic diversity in cholera patients

Rapid evolutionary turnover of mobile genetic elements drives bacterial resistance to phages

Phage predation, disease severity and pathogen genetic diversity in cholera patients

Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants

Diversified repertoire of phage resistance in and bidirectional steering effects impacting antibiotic susceptibility

Sporadic phage defense in epidemic Vibrio cholerae mediated by the toxin-antitoxin system DarTG is countered by a phage-encoded antitoxin mimic

Evolution of Bacterial Cross-Resistance to Lytic Phages and Albicidin Antibiotic

Phage-driven coevolution reveals trade-off between antibiotic and phage resistance in Salmonella anatum

Increased mutations in lipopolysaccharide biosynthetic genes cause time-dependent development of phage resistance in Salmonella

Pathogenicity islands and phages in Vibrio cholerae evolution

Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy

Genomic and biological insights of bacteriophages JNUWH1 and JNUWD in the arms race against bacterial resistance

Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci

Phage-induced efflux down-regulation boosts antibiotic efficacy

Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms

Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae

The impact of phage and phage resistance on microbial community dynamics

The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage